Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Recursion Pharmaceuticals reported mixed Q2 results, with revenue declining to $7.67 million. However, the company made significant strides in drug discovery and received FDA clearance for a new trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results